Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Treatment of obesity as a potential complementary approach to cancer therapy.

Sirin O, Kolonin MG.

Drug Discov Today. 2013 Jun;18(11-12):567-73. doi: 10.1016/j.drudis.2012.05.008. Epub 2012 May 22. Review.

PMID:
22627005
2.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

3.

Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach.

Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Bustos M, Martínez JA, Moreno-Aliaga MJ.

Biochim Biophys Acta. 2011 Jun;1807(6):664-78. doi: 10.1016/j.bbabio.2010.11.004. Epub 2010 Nov 24. Review.

4.

[Challenges in the treatment of patients with type 2 diabetes mellitus and obesity].

Manzanares Errazu JM.

Nutr Hosp. 2002 Feb;17 Suppl 1:1-6. Review. Spanish.

PMID:
11928531
5.

Populus balsamifera L. (Salicaceae) mitigates the development of obesity and improves insulin sensitivity in a diet-induced obese mouse model.

Harbilas D, Brault A, Vallerand D, Martineau LC, Saleem A, Arnason JT, Musallam L, Haddad PS.

J Ethnopharmacol. 2012 Jun 14;141(3):1012-20. doi: 10.1016/j.jep.2012.03.046. Epub 2012 Apr 4.

PMID:
22504062
6.

Current updates in the medical management of obesity.

Khan A, Raza S, Khan Y, Aksoy T, Khan M, Weinberger Y, Goldman J.

Recent Pat Endocr Metab Immune Drug Discov. 2012 May;6(2):117-28. Review.

PMID:
22435392
7.

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.

Cao Y.

Nat Rev Drug Discov. 2010 Feb;9(2):107-15. doi: 10.1038/nrd3055. Review.

PMID:
20118961
8.

Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications.

Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, Snitker S, Horenstein RB, Hull K, Goldberg NH, Goldberg AP, Shuldiner AR, Fried SK, Gong DW.

PLoS Med. 2006 Jun;3(6):e287.

9.

Adipose targets for obesity drug development.

Boss O, Bergenhem N.

Expert Opin Ther Targets. 2006 Feb;10(1):119-34. Review.

PMID:
16441232
10.

Emerging pharmacological approaches to the treatment of obesity.

Wasan KM, Looije NA.

J Pharm Pharm Sci. 2005 Aug 5;8(2):259-71. Review.

11.

FGF21: a novel prospect for the treatment of metabolic diseases.

Kharitonenkov A, Shanafelt AB.

Curr Opin Investig Drugs. 2009 Apr;10(4):359-64. Review.

PMID:
19337957
12.

Strategies and potential molecular targets for obesity treatment.

Campfield LA, Smith FJ, Burn P.

Science. 1998 May 29;280(5368):1383-7. Review.

PMID:
9603722
13.

Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.

Weyer C, Gautier JF, Danforth E Jr.

Diabetes Metab. 1999 Mar;25(1):11-21. Review.

14.

Obesity and cancer: the role of dysfunctional adipose tissue.

van Kruijsdijk RC, van der Wall E, Visseren FL.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78. doi: 10.1158/1055-9965.EPI-09-0372. Epub 2009 Sep 15. Review.

15.
16.

The effects of incretins on energy homeostasis: physiology and implications for the treatment of type 2 diabetes mellitus and obesity.

Karras S, Goulis DG, Mintziori G, Katsiki N, Tzotzas T.

Curr Vasc Pharmacol. 2012 Nov;10(6):781-91. Review.

PMID:
22272906
17.
18.

Medical therapy for the patient with obesity.

Bray GA, Ryan DH.

Circulation. 2012 Apr 3;125(13):1695-703. doi: 10.1161/CIRCULATIONAHA.111.026567. Review. No abstract available.

19.

The prevention and treatment of metabolic syndrome and high-risk obesity.

Molavi B, Rasouli N, Kern PA.

Curr Opin Cardiol. 2006 Sep;21(5):479-85. Review.

PMID:
16900012
20.

Pharmaceutical approaches to the treatment of obesity.

Jandacek RJ, Woods SC.

Drug Discov Today. 2004 Oct 15;9(20):874-80. Review.

PMID:
15475320
Items per page

Supplemental Content

Write to the Help Desk